Compare FTNT & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTNT | MDT |
|---|---|---|
| Founded | 2000 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.4B | 107.0B |
| IPO Year | 2009 | 2014 |
| Metric | FTNT | MDT |
|---|---|---|
| Price | $176.33 | $89.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 25 | 21 |
| Target Price | $85.71 | ★ $108.21 |
| AVG Volume (30 Days) | 3.6M | ★ 8.8M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | ★ 7.08 | 3.32 |
| EPS | ★ 1.54 | 1.14 |
| Revenue | $6,799,600,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $14.02 | $8.91 |
| Revenue Next Year | $10.51 | $6.54 |
| P/E Ratio | $112.66 | ★ $77.63 |
| Revenue Growth | ★ 14.17 | 8.43 |
| 52 Week Low | $73.55 | $73.31 |
| 52 Week High | $181.37 | $106.33 |
| Indicator | FTNT | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 59.98 | 39.16 |
| Support Level | $148.09 | $85.35 |
| Resistance Level | N/A | $89.00 |
| Average True Range (ATR) | 6.46 | 1.75 |
| MACD | 0.90 | -0.72 |
| Stochastic Oscillator | 81.48 | 14.78 |
Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.